We have collected information about Intracoronary Delivery Of Stem Cells for you. Follow the links to find out details on Intracoronary Delivery Of Stem Cells.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2983442/
Using the pig model, intracoronary delivery of mesenchymal stem cells containing fluorescent and iron nanoparticles following myocardial infarction and reperfusion results in substantially more cells deposited in the infarcted and border zones. The total...Author: Quang T Bui, Zachary M Gertz, Robert L Wilensky
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3807652/
Jul 09, 2013 · Other adult stem cells, such as mesenchymal stem cells (MSCs) 34–36 and CDCs 6, have been shown to produce microvascular occlusion after intracoronary delivery, raising concern over the use of this approach inAuthor: Roberto Bolli, Xian Liang Tang, Santosh K. Sanganalmath, Ornella Rimoldi, Federico Mosna, Ahmed Abde...
https://www.sciencedirect.com/science/article/pii/S1043067916301320
Clinical protocols for stem cell-based therapies are currently under development for patients with hypoplastic left heart syndrome. An ideal cell delivery method should have minimal safety risks and provide a wide distribution of cells to the nonischemic right ventricle (RV).Author: Brody Wehman, Osama Siddiqui, Godly Jack, Mark Vesely, Tieluo Li, Rachana Mishra, Sudhish Sharma, Br...
https://stemcellres.biomedcentral.com/articles/10.1186/scrt29
Sep 23, 2010 · Using the pig model, intracoronary delivery of mesenchymal stem cells containing fluorescent and iron nanoparticles following myocardial infarction and reperfusion results in substantially more cells deposited in the infarcted and border zones. The total numbers of cells for each section are shown as gray bars.Author: Quang T Bui, Zachary M Gertz, Robert L Wilensky
https://www.sciencedirect.com/science/article/pii/B9780128018880000229
Intracoronary infusion has been the most popular mode of stem cell delivery in the clinical setting, especially after AMI. The intracoronary delivery of stem cells has been shown to be safe at 4–9 days after an AMI in the clinical setting , , , , , , .The stop-flow technique used for intracoronary delivery is similar to that used for coronary angioplasty, which involves over-the-wire ...Author: Emerson C. Perin
https://www.researchgate.net/publication/46412734_Intracoronary_delivery_of_bone-marrow-derived_stem_cells
In this study, we sought to address these questions by directly comparing the effect of bone marrow-derived mesenchymal stem cells and unrestricted somatic stem cells delivered 24 hours post ...
https://www.ahajournals.org/doi/10.1161/circulationaha.112.001075
Intracoronary infusion is an attractive method for cell delivery to the heart because it can disseminate cells relatively uniformly to the entire region infused, 25 it is widely available clinically, it is less invasive than intramyocardial injection, and it has been used in numerous clinical trials. 26 – 33 Other adult stem cells…Author: Roberto Bolli, Xian Liang Tang, Santosh K. Sanganalmath, Ornella Rimoldi, Federico Mosna, Ahmed Abde...
http://www.onlinejacc.org/content/47/8/1727
Apr 18, 2006 · Journal of the American College of Cardiology. ... Intracoronary Delivery of Hematopoietic Bone Marrow Stem Cells and Luminal Loss of the Infarct-Related Artery in Patients With Recent Myocardial Infarction. Samer Mansour, Marc Vanderheyden, ...Author: Samer Mansour, Marc Vanderheyden, Bernard De Bruyne, Bart Vandekerckhove, Leen Delrue, Inge Van Haut...
http://europepmc.org/articles/PMC4610677
Llano R, Epstein S, Zhou R, Zhang H, Hamamdzic D, Keane MG, et al. Intracoronary delivery of mesenchymal stem cells at high flow rates after myocardial infarction improves distal coronary blood flow and decreases mortality in pigs. Catheter Cardiovasc Interv. 2009; 73:251–257. [PMC free article]Author: António Fiarresga, Márcia F. Mata, Sandra Cavaco-Gonçalves, Mafalda Selas, Irina N. Simões, Eunice O...
https://www.semthorcardiovascsurg.com/article/S1043-0679(16)30132-0/pdf
stem cell delivery to the RV has yet to be explored in a preclinical model, necessary for a hypoplastic left heart syndrome trial. Human c-kitþ cardiac stem cells (CSCs) were delivered to healthy Yorkshire swine through the proximal right coronary artery with a stop and reflow technique. The effect of
Searching for Intracoronary Delivery Of Stem Cells?
You can just click the links above. The data is collected for you.